Regina Alemany

University Of The Balearic Islands
Palma, PM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma.

Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: September 06, 2024

Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience.

Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience.

Journal: Frontiers in immunology

Published: July 26, 2023

Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma.

Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma.

Journal: Cancers

Published: January 14, 2022

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?

Journal: Cancers

Published: September 15, 2021

Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma.

Prognostic Role of the Red Blood Cell Distribution Width (RDW) in Hodgkin Lymphoma.

Journal: Cancers

Published: September 27, 2020

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study.

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study.

Journal: Cancers

Published: August 11, 2020

Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas.

Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas.

Journal: Cancers

Published: August 06, 2020

Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma.

Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 20, 2018

Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas-Response.

Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas-Response.

Journal: Molecular cancer therapeutics

Published: October 05, 2017

Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells.

Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells.

Journal: Molecular cancer therapeutics

Published: September 12, 2016

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 18, 2016

Down-Regulation of AKT Signalling by Ursolic Acid Induces Intrinsic Apoptosis and Sensitization to Doxorubicin in Soft Tissue Sarcoma.

Down-Regulation of AKT Signalling by Ursolic Acid Induces Intrinsic Apoptosis and Sensitization to Doxorubicin in Soft Tissue Sarcoma.

Journal: PloS one

Published: October 02, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026